Johnson & Johnson (JNJ) Payables (2009 - 2026)

Johnson & Johnson has disclosed Payables across 18 years of filings, most recently posting $27.9 billion for Q1 2026.

• Payables for Q1 2026 came in at $27.9 billion, up 19.1% year-over-year; the trailing twelve-month figure through Mar 2026 was $27.9 billion (up 19.1% YoY), and the FY2025 annual result was $20.5 billion, up 25.73% from the prior year.
• Payables came in at $27.9 billion for Q1 2026 at Johnson & Johnson, up from $20.5 billion in the prior quarter.
• In the past five years, Payables ranged from a high of $27.9 billion in Q1 2026 to a low of $12.2 billion in Q4 2023.
• The 5-year median for Payables is $16.5 billion (2024), against an average of $18.3 billion.
• Peak annual rise in Payables reached 104.97% in 2023, while the deepest fall reached 42.23% in 2023.
• Johnson & Johnson's Payables stood at $14.6 billion in 2022, then retreated by 10.25% to $13.1 billion in 2023, then grew by 24.54% to $16.3 billion in 2024, then increased by 25.73% to $20.5 billion in 2025, then jumped by 36.29% to $27.9 billion in 2026.
• The last three Payables figures came in at $27.9 billion (Q1 2026), $20.5 billion (Q4 2025), and $16.0 billion (Q3 2025), per Business Quant data.